Overexpression of flavin-containing monooxygenase 5 predicts poor prognosis in patients with colorectal cancer
Authors:
- 4 January 2018
- journal article
- research article
- Published by Spandidos Publications in Oncology Letters
- Vol. 15 (3) , 3923-3927
Abstract
The present study investigated the expression and clinical significance of flavin‑containing monooxygenase 5 (FMO5) in colorectal cancer (CRC). The expression of FMO5 was detected by immunohistochemistry in 208 colon cancer tissues and 8 normal colon tissues. Then, the correlations of FMO5 expression with several clinicopathological features were evaluated. FMO5 mRNA expression from The Cancer Genome Atlas dataset was assessed for further validation. In addition, the association of the expression of FMO5 with prognosis was further evaluated by Kaplan‑Meier survival curves and Cox proportional hazards model. The FMO5 protein level in colon cancer tissues was significantly higher than that in normal colon tissues (P<0.001). Overexpression of FMO5 was associated with an advanced clinical stage of cancer (P=0.018) and lymph node metastasis (P=0.03). The TCGA dataset also demonstrated that FMO5 was upregulated in CRC with advanced clinical stage (P=0.047), lymph node metastasis (P=0.045) and distant metastasis (P=0.030). The Kaplan‑Meier survival curves showed that higher FMO5 mRNA indicated a shorter overall survival in patients with CRC compared with a low expression of FMO5 (P=0.029). Cox proportional hazards regression revealed that a high FMO5 mRNA level served as an independent prognostic factor for patients with CRC (hazard ratio, 2.865; 95% confidence interval, 1.116‑7.355; P=0.029). A high expression of FMO5 may serve roles in colorectal carcinogenesis and distant metastasis. FMO5 may be an independent predictive factor for the prognosis of CRC.Keywords
This publication has 23 references indexed in Scilit:
- The Global Burden of Cancer 2013JAMA Oncology, 2015
- Flavin-containing monooxygenase S-oxygenation of a series of thioureas and thionesToxicology and Applied Pharmacology, 2014
- Mammalian flavin-containing monooxygenase (FMO) as a source of hydrogen peroxideBiochemical Pharmacology, 2014
- St. John's wort and its constituent hyperforin concordantly regulate expression of genes encoding enzymes involved in basic cellular pathwaysPharmacogenetics and Genomics, 2005
- Mammalian flavin-containing monooxygenases: structure/function, genetic polymorphisms and role in drug metabolismPharmacology & Therapeutics, 2005
- S-oxidation ofS-methyl-esonarimod by flavin-containing monooxygenases in human liver microsomesXenobiotica, 2003
- Colorectal Carcinoma: Diagnostic, Prognostic, and Molecular FeaturesLaboratory Investigation, 2003
- Rifampin Is a Selective, Pleiotropic Inducer of Drug Metabolism Genes in Human Hepatocytes: Studies with cDNA and Oligonucleotide Expression ArraysThe Journal of Pharmacology and Experimental Therapeutics, 2001
- Progesterone Regulated Expression of Flavin-Containing Monooxygenase 5 by the B-Isoform of Progesterone Receptors: Implications for Tamoxifen CarcinogenicityThe Journal of Clinical Endocrinology & Metabolism, 1997
- The requirement for flavin adenine dinucleotide by a liver microsomal oxygenase catalyzing the oxidation of alkylaryl aminesBiochemical and Biophysical Research Communications, 1964